cedilanid + furosemide

Cedilanid + furosemide is a combination of two pharmaceutical agents used primarily in the management of heart failure and related conditions. Cedilanid (also known as deslanoside) is a cardiac glycoside that increases myocardial contractility by inhibiting the sodium/potassium-transporting ATPase, leading to increased intracellular calcium and enhanced cardiac output. Furosemide is a loop diuretic that acts on the ascending limb of the loop of Henle in the kidney, inhibiting chloride reabsorption and promoting significant diuresis. The combination may be used to manage congestive heart failure by improving cardiac function (cedilanid) while reducing fluid overload (furosemide). This dual approach addresses both impaired contractility and volume overload, common features in advanced heart failure[2][3]. However, combining these drugs requires careful monitoring due to risks such as electrolyte disturbances (notably hypokalemia), arrhythmias, and renal dysfunction.